It is a scenario familiar to virtually every infectious disease clinician: a patient exhibits unambiguous signs of infection, yet the results of cultures of appropriate clinical specimens remain negative. This hinders our ability to answer an important clinical question: "who"-in the microbial sense-is present at the disease site? Absent this information, empirical therapy is guided by the answer to a second pressing question: "who" could potentially be present? To answer this query for a given infectious syndrome requires knowledge of the diversity of microbial taxa that contribute to pathology at an anatomic site of interest. At the same time, we must avoid jumping to conclusions of "guilt" based solely on findings of colocalization with pathology; not all microbial species found in an abscess, in particular, are critical to-or even involved in-pathogenesis, nor do they necessarily require targeted therapy.
In this issue, Al Masalma et al. [1] provide the most revealing glimpse to date of bacterial diversity within brain abscesses. Brain abscesses continue to be an important clinical problem: the mortality rate among immunocompetent patients remains as high as 4%-12% in the current era of CT [2, 3] , and the incidence of neurologic sequelae is 120% [2] . However, despite the seriousness of this syndrome, the clinical benefit of identifying the lessabundant microbial constituents in abscesses remains unproven. We know from animal models, however, that polymicrobial infections are often complex, dynamic, and interactive processes. For example, avirulent [4, 5] and even beneficial [6] bacterial strains may synergistically enhance pathogenicity as part of a microbial community. Pathogen synergy is orchestrated by elaborate interactions [6] between microbes possessing diverse capabilities, including, among others, biofilm formation [7] , phagocytosis inhibition [8] , redox potential reduction [9] , toxin production [10] , nutrient provision [9] , and transcriptional modulation of virulence factors in colocated species [6] . Furthermore, marked population shifts in absolute and relative abundance of diverse microbial species may occur during the evolution of a polymicrobial infection [11] . Although the role of numerically nondominant microbial taxa in initiating, maintaining, and exacerbating brain abscesses has been little studied, it makes sense to begin by first documenting and enumerating potential "players," including any statistically significant co-occurrence of specific microbial groups.
In their study, Al Masalma et al.
[1] used a PCR-and sequence-based approach that exploits 16S ribosomal DNA (rDNA) to profile bacterial diversity. The rationale for this cultivation-independent strategy is clear. It has long been recognized that many microbes visualized by microscopy cannot be cultivated [12] . Despite advances in cultivation technology, у99% of the microbial species residing in various habitats cannot be recovered by available techniques, a phenomenon termed the "great plate count anomaly" [13] . In addition, attempts to isolate even cultivable pathogens may fail. This is especially true for fastidious microbial groups, such as microaerophiles and strict anaerobes, members of which are often found in brain abscesses [2, 3, 14] . Finally, the yield from microbial cultivation may be compromised when antibiotic administration precedes the sampling of brain abscess material [3] . To overcome shortcomings of culture, Al Masalma and colleagues amplified bacterial 16S rDNA sequences from intra-operatively collected abscess specimens [1] by means of broadrange PCR primers. These primers target sites of known sequence conservation within the 16S rRNA gene while enabling amplification of intervening regions of high sequence variability. These variable regions effectively act as an "evolutionary chronometer," a characteristic that has been leveraged to infer microbial phylogeny ever since the pioneering work of Carl Woese and colleagues in the 1970s [15] .
Al Masalma et al. [1] analyzed 16S rDNA amplicons by means of 3 progressively "deeper" sequencing methods: direct Sanger (traditional) sequencing of PCR products (1 sequence per sample), Sanger sequencing of individual clones from libraries (∼100 sequences per sample), and pyrosequencing of individual molecules within PCR products (∼2000 sequences per sample). Results from this polyphasic molecular approach were compared with those from the gold standard approach, cultivation. Seventeen of the 20 analyzed samples had positive culture results, yielding a total of 14 different bacterial species. Each of the 3 progressively comprehensive molecular methods lengthened this list of encountered bacterial taxa commensurately.
Sequencing approaches, in general, appear to be particularly useful in cases in which patients received antibiotics before the retrieval of clinical material for culture analysis [16, 17] , as occurred in 2 subjects in the study by Al Masalma et al. [1] . The first approach in this study, direct Sanger sequencing (termed "single sequencing" in the manuscript), increased the microbial roster from 14 to 18 [1] . These 4 additional taxa were detected in 4 study subjects, including the 3 whose samples yielded negative culture results. A direct sequencing approach has been previously used to detect microbes in brain abscesses [16] [17] [18] [19] . A limitation of direct sequencing, however, is its unreliability in providing phylogenetic resolution of polymicrobial infections; culture-based studies suggest that up to 60% of brain abscesses may be of polymicrobial origin [3, 20] , and this is likely an underestimation. The second approach, Sanger sequencing of clone libraries, is considered the current gold standard technique among molecular approaches for surveying microbial diversity. It has been used to reveal previously unsuspected diversity in various anatomic niches in human health [21] and disease [22] and for characterizing uncultivated human pathogens [23] . This approach yielded 26 microbial sequence types not detected by culture or direct sequencing, thereby further increasing the number of taxa encountered by Al Masalma et al. [1] from 18 to 44. Among the newly identified taxa were Mycoplasma faucium (in 3 subjects) and 17 other phylotypes for which the authors found no previous reports in the setting of brain abscess. The third approach, pyrosequencing, exploits newer, massively parallel sequencing technology capable of providing tens of thousands of sequence "tags" (relatively short reads of hypervariable regions) for the same cost and with less time and labor as hundreds of sequences when provided by traditional Sanger sequencing. Al Masalma and colleagues applied pyrosequencing analysis to 1 sample, which yielded 8 taxa in addition to those detected with the other approaches. The authors report that none of these 8 taxa have been previously detected in brain abscesses [1] . This intriguing finding deserves attention but should be interpreted cautiously, because pyrosequencing analysis may be particularly prone to overestimating diversity. One factor is the disproportionate effect that even a single sequencing error has on the similarity score of a short read (pyrosequencing tags were ∼100 bp in this study). Also, because a pyrosequencing tag is hypervariable across its entire length, analysis may warrant a greater sequence dissimilarity threshold to define a unique phylotype than that used for analysis of 16S rDNA sequences that span both hypervariable and conserved regions.
Tabulating the diverse microbial taxa associated with a given state of health or disease could be likened to the polling of households within a geographic area to profile the region's inhabitants. Pyrosequencing is particularly well suited for such community census-taking because of its ability to track minority constituents of complex microbial communities. When surveyed in depth (i.e., by both pyrosequencing and clone library analysis), an abscess appears to harbor much richer diversity than we would have suspected on the basis of conventional methods alone [1] . In fact, pyrosequencing has been used recently to reveal new insights into both commensal [24] [25] [26] [27] and disease-associated [28] [29] [30] human microbiota and to detect human pathogens [31] .
Molecular approaches-and the study by Al Masalma et al. [1] as an examplehave limitations. Molecular findings may be skewed by PCR amplification biases, owing in part to primer mismatches to targeted rDNA sequences. Evidence for this can be seen in the findings from the lone patient whose sample was analyzed with both "multiple sequencing" approaches: each used a different primer pair, and each yielded some unique taxa. Another limitation of pyrosequencing is the restricted phylogenetic resolving power of the relatively short sequence tags that are generated (∼100 bp in this study and ∼400 bp with current technology); on the other hand, pyrosequencing avoids the biases inherent in cloning. Despite these and other limitations, the application of ecological statistics [32] to the findings of Al Masalma and colleagues suggests that there is much more waiting to be discovered from continued molecular surveys of abscesses.
The important findings of Al Masalma et al. [1] raise as many questions as they do answers. For example, one may ask "who else-in addition to bacteria-is there?" Many polymicrobial brain abscesses originate from odontogenic infections, and we now know that members of the domain Archaea have been associated with periodontal disease [33, 34] and endodontic infection [35] . Beyond asking, "Who is there?" one might also wonder, "What, precisely, are they doing?" and "How are they doing it?" Probing these types of important functional questions might be accomplished through carefully designed studies that collect appropriate clinical metadata and include proteomic [36, 37] , metagenomic [27, 38, 39] , or transcriptomic [40] approaches. These are not issues of solely intellectual interest. Insights into microbial community physiology and pathogenesis from these efforts may lead to novel approaches for predicting, interrupting, and preventing abscess formation. Microbes are gregarious and interactive by nature. We, as clinicians, should give greater attention to this fact as we consider new strategies for characterizing and managing infectious diseases of possible polymicrobial origin.
